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Background: TAVI is an emerging technique for treating non operable patients with severe aortic stenosis (AS). We report our one year clinical, and 
echo follow up of our TAVI program
Methods: All patients who were eligible, and underwent TAVI therapy have been followed in our clinic, and echocardiography lab at six and 12 
months program. Detailed clinical, and echo evaluation have been performed for those patients.
Results: 33 patients were operated, with mean age of 78.7± 9.3 y, 18 males, and 14 females. The procedure was aborted in 2 patients, one trans-
femoral due to low left main uptake, and one trans-apical due to bleeding. Minor stroke developed in 2 patients, peripheral arterial complication in 
3 patients, and permanent pacemaker was inserted in 1 patient. The patients were followed for mean of 12 ± 6 months. Two patients died within one 
week, and one died after 4 weeks giving mortality rate of 9.6 %. On follow up, patient’s symptoms improved. The peak aortic gradient decreased from 
88 ± 22 mmhg to 19 ± 7 mmhg, P < 0.0001, and the mitral regurgitation (MR) severity decreased from grade1.6 ± 1.1 to 0.9 ± 0.6, P< 0.001. Two 
patients developed moderate paravalvular leak, and 5 developed mild leak.
Conclusion: TAVI is promising technique in treating patients with severe AS with acceptable mortality rate. There was significant improvement in 
patient’s symptoms, reduction in aortic valve gradient and reduction in MR severity.
